Carbon sequestration material developer Verde Resources (VRDR.US) has submitted an IPO application, aiming to raise $6 million.
Verde Resources submitted an IPO application to the U.S. Securities and Exchange Commission (SEC) on Tuesday, with plans to raise up to $6 million through an initial public offering.
Verde Resources submitted an IPO application to the Securities and Exchange Commission (SEC) on Tuesday, planning to raise up to 6 million US dollars through an initial public offering. The company focuses on developing carbon sequestration materials for road construction and is currently listed on the Over-The-Counter (OTC) market under the ticker symbol "VRDR". Specific pricing terms have not been disclosed yet.
Verde Resources is a road construction and building materials company with authorization for BioAsphalt and a patented emulsifier called Verde V24. Its technology has been verified by third-party testing at the National Center for Asphalt Technology (NCAT) and has undergone 50,000 single-axle load tests. As of September 30, 2025, the company has produced 80,000 liters of Verde V24. According to an authorization agreement with Ergon covering the United States, Canada, and Mexico, the company also has a facility in Borneo capable of producing up to 6,000 tons of biochar annually.
This company, headquartered in St. Louis, Missouri, was founded in 2010 and recorded revenue of $10,000 in the 12 months ending September 30, 2025. Verde Resources submitted a confidential filing for listing on the Nasdaq on June 30, 2025. Maxim Group LLC is the sole bookrunner for this transaction.
Related Articles

On January 16, BEKE-W (02423) spent $3.5 million to repurchase 603,500 shares.

New stock news | Qinhao Pharmaceuticals submits application to Hong Kong Stock Exchange, mainly focusing on developing potential best-in-class targeted therapies in the field of oncology.
.png)
New Stock Update | Moganshan Home Delivery Form to Hong Kong Stock Exchange, serving as China's third largest green artificial board service provider.
On January 16, BEKE-W (02423) spent $3.5 million to repurchase 603,500 shares.

New stock news | Qinhao Pharmaceuticals submits application to Hong Kong Stock Exchange, mainly focusing on developing potential best-in-class targeted therapies in the field of oncology.

New Stock Update | Moganshan Home Delivery Form to Hong Kong Stock Exchange, serving as China's third largest green artificial board service provider.
.png)





